Skip to main content

Table 2 Summary of outcomes categorised according to the COMET taxonomy

From: SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials

Core area

Core domains

Trials including one or more outcome in core domain (n (%))

Outcomes included in core domain (n (%))

Trials including as a primary outcomea (n)

Death

Mortality/survival

3 (2.2)

3 (0.2)

0

Physiological/clinical

Blood and lymphatic system outcomes

9 (6.5)

19 (1.3)

1

Cardiac outcomes

20 (14.5)

56 (3.9)

9

Congenital, familial and genetic outcomes

0(0)

0 (0)

 

Endocrine outcomes

31(22.5)

50 (3.5)

7

Ear and labyrinth outcomes

0 (0)

0 (0)

0

Eye outcomes

2 (1.4)

2 (0.1)

0

Gastrointestinal outcomes

5 (3.6)

20 (1.4)

2

General outcomes

65 (47.1)

146 (10.1)

3

Hepatobiliary outcomes

12 (8.7)

25 (1.7)

3

Immune system outcomes

28 (20.3)

73 (5.1)

4

Infection and infestation outcomes

4 (2.9)

8 (0.6)

0

Injury and poisoning outcomes

0 (0)

0 (0)

0

Metabolism and nutrition outcomes

121 (87.7)

582 (40.3)

92

Musculoskeletal and connective tissue outcomes

2 (1.4)

2 (0.1)

1

Outcomes relating to neoplasms: benign, malignant and unspecified (including cysts and polyps)

0 (0)

0 (0)

0

Nervous system outcomes

6 (4.3)

16 (1.1)

2

Pregnancy, puerperium and perinatal outcomes

0 (0)

0 (0)

0

Renal and urinary outcomes

27 (19.6)

76 (5.3)

5

Reproductive system and breast outcomes

0 (0)

0 (0)

0

Psychiatric outcomes

2 (1.4)

2 (0.1)

0

Respiratory, thoracic and mediastinal outcomes

3 (2.2)

11 (0.8)

1

Skin and subcutaneous tissue outcomes

1 (0.7)

1 (0.1)

0

Vascular outcomes

51 (37)

134 (9.3)

13

Physical functioning

5 (3.6)

7 (0.5)

0

Life impact

Social functioning

5 (3.6)

6 (0.4)

0

Role functioning

3 (2.2)

6 (0.4)

0

Emotional functioning/wellbeing

8 (5.8)

28 (1.9)

0

Cognitive functioning

2 (1.4)

22 (1.5)

0

Global quality of life

4 (2.9)

5 (0.3)

0

Perceived health status

4 (2.9)

4 (0.3)

0

Delivery of care

30 (21.7)

60 (4.2)

4

 

Personal circumstance

0 (0)

0 (0)

0

Resource use

Economic

4 (4)

6 (0.4)

0

Hospital

3 (2.2)

4 (0.3)

0

Need for intervention

16 (11.6)

24 (1.7)

1

Societal/carer burden

0 (0)

0 (0)

0

Adverse events

Adverse events/effects

33 (23.9)

46 (3.2)

5

  1. aSome trials included more than one primary outcome